Literature DB >> 7921441

Accumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individuals.

N Maruyama1, G Tamura, T Aizawa, T Ohrui, S Shimura, K Shirato, T Takishima.   

Abstract

To investigate cellular differentials in natural airway narrowing of steroid-dependent asthmatic individuals, we performed bronchoalveolar lavage (BAL) on 10 inpatients with asthma treated only with bronchodilators during episodes of natural airway narrowing evaluated by serial monitoring of peak expiratory flow (PEF), and on nine normal volunteers. We confirmed that the airway narrowing was not completely reversed by salbutamol aerosol just before the BAL study, but was completely reversed by administration of systemic steroid after the BAL study. Thus, the natural airway narrowing investigated in this study consisted not only of the constriction of airway smooth muscle, but also of edema of the airway mucosa and/or secretion in airways. Both the numbers and percentages of eosinophils and alcian blue-positive cells in BAL fluids from the asthmatic subjects were significantly higher than those of normals, but the numbers and percentages of neutrophils, lymphocytes, and macrophages were not. Thus, eosinophils and alcian blue-positive cells selectively increased in the airways during the natural airway narrowing. Because we found that the metachromatic cells consisted of two types, with a single nucleus and with segmented nuclei, we further examined basophil chemotactic activity (BCA) in BAL fluids. We showed that BCA was significantly higher in the asthmatic (79.3 +/- 17.2 cells/5 hpf) than in the normal subjects (6.2 +/- 1.6 cells/5 hpf), and also that the activity was more strongly correlated with the cells having segmented nuclei (p = 0.95) than with all of the cells (p = 0.73).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921441     DOI: 10.1164/ajrccm.150.4.7921441

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 2.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

3.  Stability of Syk protein and mRNA in human peripheral blood basophils.

Authors:  Donald MacGlashan
Journal:  J Leukoc Biol       Date:  2016-03-15       Impact factor: 4.962

4.  Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.

Authors:  Michel Laviolette; David L Gossage; Gail Gauvreau; Richard Leigh; Ron Olivenstein; Rohit Katial; William W Busse; Sally Wenzel; Yanping Wu; Vivekananda Datta; Roland Kolbeck; Nestor A Molfino
Journal:  J Allergy Clin Immunol       Date:  2013-07-16       Impact factor: 10.793

Review 5.  Important and specific role for basophils in acute allergic reactions.

Authors:  P Korošec; B F Gibbs; M Rijavec; A Custovic; P J Turner
Journal:  Clin Exp Allergy       Date:  2018-03-23       Impact factor: 5.018

Review 6.  Neutrophils in asthma pathophysiology.

Authors:  Madeleine Ennis
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

Review 7.  Benralizumab: a unique IL-5 inhibitor for severe asthma.

Authors:  Laren D Tan; Jennifer M Bratt; Dorottya Godor; Samuel Louie; Nicholas J Kenyon
Journal:  J Asthma Allergy       Date:  2016-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.